ArticlePDF Available

Abstract and Figures

Personalised nutrition can be defined as developing unique nutrition guidelines for each individual; precision nutrition seeks to develop effective approaches based on the combination of an individual's genetic, environmental and lifestyle factors. The former infers variants that underlie traits are largely fixed (i.e. stable across time) and appeals to the notion that we are inherently different from one another. The latter opens up the possibility that what we do and where we are may be more important than what we are. While there are undoubtedly a specific minority of individuals who clearly require a more personalised approach to nutrition, several criteria must be fulfilled before we can justify or implement personalised nutrition for the general population. These would include identifying a desired health outcome and a valid predictor of how that outcome changes, which can be measured with sufficient accuracy and exhibit a robust correlation and/or causal relationship in the required direction (i.e. predictor-response). Many attempts to personalise nutrition, such as profiling the genome or microbiome, do not currently meet all these criteria. Therefore, we argue that there is presently insufficient rationale for truly personalised nutrition for the majority of people based on the inter-individual differences that separate them. Conversely, we propose that precision nutrition based on the environmental and/ or behavioural 'lifestyle' variance within each person may provide a more effective basis for adjusting diet dynamically, with recognition of varying physiological demands and requirements over time.
Content may be subject to copyright.
Personalised nutrition: What makes you
so special?
J. A. Betts and J. T. Gonzalez
Department for Health, University of Bath, Bath, UK
Abstract Personalised nutrition can be defined as developing unique nutrition guidelines
for each individual; precision nutrition seeks to develop effective approaches
based on the combination of an individual’s genetic, environmental and lifestyle
factors. The former infers variants that underlie traits are largely fixed (i.e. stable
across time) and appeals to the notion that we are inherently different from one
another. The latter opens up the possibility that what we do and where we are
may be more important than what we are. While there are undoubtedly a specific
minority of individuals who clearly require a more personalised approach to
nutrition, several criteria must be fulfilled before we can justify or implement
personalised nutrition for the general population. These would include
identifying a desired health outcome and a valid predictor of how that outcome
changes, which can be measured with sufficient accuracy and exhibit a robust
correlation and/or causal relationship in the required direction (i.e. predictor-
response). Many attempts to personalise nutrition, such as profiling the genome
or microbiome, do not currently meet all these criteria. Therefore, we argue that
there is presently insufficient rationale for truly personalised nutrition for the
majority of people based on the inter-individual differences that separate them.
Conversely, we propose that precision nutrition based on the environmental and/
or behavioural ‘lifestyle’ variance within each person may provide a more
effective basis for adjusting diet dynamically, with recognition of varying
physiological demands and requirements over time.
Keywords: metabolic profiling, microbiota, nutrition, public health
Introduction
The concept of personalised nutrition is inherently
appealing to human egotism; simple messages recog-
nising individuality therefore resonate deeply with
consumers. This may explain the popularity of such
messages in sales and marketing, with uniquely
designed products intuitively assumed to be superior
and considered more exclusive than a ‘one-size-fits-all’
approach. Ironically, this very reasoning often culmi-
nates not in bespoke products that recognise each indi-
vidual as truly unique but rather ‘personalisation’ is
achieved by fitting groups of people into discrete cate-
gories once each individual has been branded with the
fixed label of a certain ‘type’ (i.e. stratified nutrition;
Smith 2012). Whilst the number and specificity of cat-
egories may vary (e.g. from sex differences to genetic
profiling), the ‘type’ of person you are is generally
considered to be a stable characteristic. This means
that these categories must be mutually exclusive and
represent a comprehensive list of all possible types of
people.
Correspondence: Dr. James A. Betts, FACSM, Reader in Nutrition
& Metabolism Department for Health, University of Bath, Bath
BA2 7AY, UK.
E-mail: j.betts@bath.ac.uk
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359 353
NEWS AND VIEWS DOI: 10.1111/nbu.12238
There are undoubtedly some phenotypes (albeit those
that are typically rare or transient conditions) that may
justifiably be categorised as having distinct metabolic
requirements and thus special dietary needs (e.g. con-
genital metabolic disorders or pregnancy; McNulty
1997). However, the idea that nutritional requirements
vary sufficiently between individuals in the general pop-
ulation to justify personalised nutrition for the vast
majority is an assumption that can be questioned at a
number of levels. This opinion piece will explore the
various points at which that reasoning may not neces-
sarily be supported by sound logic or empirical evi-
dence, before considering whether and how we should
identify individual differences for incorporation into
future nutritional recommendations. As a starting
point, we propose that a practically useful approach to
personalised nutrition must fulfil at least the following
inter-related but independently essential criteria:
the ability to measure the predictive variable with
sufficient precision and accuracy;
the ability to measure the outcome variable with
sufficient precision and accuracy;
plus a robust and practically meaningful correlation
and/or causal relationship (in the required direction)
between the predictive and outcome variables.
Is personalised nutrition justified by small
differences between people?
A simple balance equation subtracting expenditure
from intake is often applied in relation to nutrition,
which can be a helpful method to express how needs
must somehow be properly met to prevent deficiency
(or excess) and thus maintain function/status. Based
on this model, if the ‘needs’ of a system require 10%
above average utilisation of a given substrate/nutrient,
it might be expected that a 10% higher dietary intake
of that substrate/nutrient would be necessary to meet
the elevated requirement. However, that reasoning
overlooks the capacity of physiological systems to
adapt to the naturally variable and unpredictable
availability of nutrients. Specifically, notwithstanding
extreme cases when sustained/severe deficiency can
result in harmful metabolic imbalances (e.g. famine)
or when an individual may require optimal function
beyond adequate health (e.g. elite athletes; Jeukendrup
2014), a surplus or deficit of a given nutrient can usu-
ally be tolerated or regulated via the interconversion,
synthesis, oxidation, excretion and/or safe storage of
nutrients to maintain homoeostasis.
The margins of error that can be managed in this
way can vary for particular nutrients and circumstances
but the point remains that variability in nutrient
requirements within the limits of our physiological
capacity may not necessitate any proportionate adjust-
ment in diet. Nonetheless, accepting that our capacity
to buffer such imbalances is limited, such that even a
minority of individuals might benefit from a person-
alised intake of certain nutrients, the next challenge is
to find measurements that reliably identify candidates
for personalised nutrition before symptoms of acute
nutritional imbalance and/or associated chronic diseases
manifest.
Can measuring differences between people
predict individual responses to personalised
nutrition?
Health professionals attempting to provide advice and
support regarding nutrition will be all too familiar
with the challenge of identifying the few individuals
for whom standard dietary guidelines may be inappro-
priate. Unfortunately, no single measurement tool cur-
rently exists that can take a snapshot of individual
physiology capable of identifying healthy individuals
before they become symptomatic in order to inform
appropriate dietary modifications in a preventative
manner. Profiling of individuals to estimate personal
nutritional requirements has been attempted using
numerous organismic variables (see left-hand column
of Table 1).
Two variables that ostensibly present the greatest
degree of accuracy and precision for predicting indi-
vidual nutrient requirements are based on profiling the
genome or microbiome of an individual yet, to date,
both approaches have relied heavily on the assump-
tions that: (i) inter-individual variability between peo-
ple can be mostly explained by the genome or
microbiome; and (ii) intra-individual variability within
each person is minor in relation to inter-individual
variability. On the first point, genetic profiling in par-
ticular undoubtedly identifies individual differences at
a fundamental level and remains popular despite the
realisation that most health outcomes cannot in fact
be meaningfully explained by common gene variants.
For example, the genetic contribution to risk of devel-
oping type 2 diabetes (a health outcome that is heavily
dependent on nutrition; Steven et al. 2016) is only
~10% (Morris et al. 2012). Even when considering
this contribution, using sequence-based genome-wide
association studies, genetic risk of type 2 diabetes is
much more strongly predicted by common risk vari-
ants than rare risk variants (Fuchsberger et al. 2016).
This makes sense from an evolutionary perspective, as
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359
354 J. A. Betts and J. T. Gonzalez
any nutrition-related health outcome that has the
greatest health impact post-reproductive age (e.g. most
cardiovascular diseases, type 2 diabetes and some can-
cers) is unlikely to have resulted in selection pressure.
Thus, the genetic risk of most nutrition-related health
outcomes is more likely to be explained by common,
rather than rare, variants. In this sense, we are more
similar to other people than we are dissimilar. The
apparent ‘missing heritability’ is perhaps best illus-
trated by the fact that >96% of the diversity in even a
relatively objective, reliably measured and strongly
(8090%) inherited phenotype, such as average adult
stature, cannot be explained by differences in the 40
genes that are collectively most predictive of human
height in the majority of cases (Gudbjartsson et al.
2008). Clearly, trying to predict complex real-world
phenomena based on just one or even multiple genes
can be like trying to tell the time using a clock with
no hour hand; precision and accuracy only become
useful in the wider context.
Despite these current limitations to genetic profiling,
there is already at least one exception to the rule that
lends hope to the promise of stratified nutrition based
on genotype in the future. Specifically, individuals
who are homozygous AA for TAP2Brs987237 lose
more weight when consuming an energy-restricted diet
that is lower in fat, whereas individuals who are
homozygous GG display greater weight loss on an
energy-restricted diet that is higher in fat (Stocks et al.
2012). In that study, however, those homozygous GG
were a small minority (4%) and the stated relationship
between genotype and body mass was not apparent
for outcomes more strongly related to adiposity and
health (e.g. waist circumference). Most importantly,
the subsequent attempt to use this particular gene
variant as a predictor of responses to high- vs. low-fat
dietary interventions was unsuccessful (Stocks et al.
2012). This finding is consistent with the results of a
recent randomised controlled trial that effectively
modified dietary behaviours by personalising nutrition
using a combination of five diet-responsive gene vari-
ants alongside phenotype and habitual diet, yet this
did not translate into enhanced health responses to
that intervention (Celis-Morales et al. 2016). While it
remains a possibility that effective stratified prescrip-
tion of diet for weight management may have been
limited by statistical power (Larsen et al. 2012; Stocks
et al. 2012), there is presently insufficient evidence to
confidently assign personalised diets according to
genotype.
With regard to microbiomic profiling, the composi-
tion of microbe species in the human gut (gut micro-
biome) is vast, with many more genes than in our
own host genome (Neish 2009). There is also evidence
for a mechanism by which gut microbes can influence
nutrition-related health outcomes, primarily through
the availability of nutrients and short-chain fatty
acids, with implications for glycaemic control, insulin
sensitivity and appetite (Byrne et al. 2015). Therefore,
it is an attractive prospect that the gut microbiome
could be used as a basis for individual level nutrition
guidance and to achieve favourable health outcomes.
An example of this was the attempted use of micro-
biomic profiling (in addition to self-reported physical
activity levels, blood glycated haemoglobin and
cholesterol concentrations) to personalise nutrition in
relation to plasma glucose responses to foods (Zeevi
et al. 2015). The lack of accurate measures of physical
activity and postprandial glycaemia mean that at least
the first two criteria for personalised nutrition pro-
posed earlier have not yet been satisfied (i.e. ‘an ability
to measure the predictive/outcome variable with suffi-
cient precision and accuracy’). With this in mind, it
has been highlighted that most of the variability in
postprandial plasma glucose responses to foods is due
to variability within individuals rather than between
individuals (Wolever 2016).
With respect to the third criterion for personalised
nutrition proposed earlier, relationships between a
Table 1 Ostensible predictors that might inform a personalised/
precision nutrition plan
Ostensible predictor
Do individual
differences predict
the benets of
personalised nutrition?*
Are individual
differences xed/stable
characteristics?
Genotype No No (epigenetics)
Gut microbiome No No
Sex No Yes
Age Yes No
Body mass Yes No
Adiposity/obesity Yes No
Pregnancy related Yes No
Physical activity Yes No
Allergy/intolerance Yes Yes
Disease state Yes Yes
*The predictive power of individual differences is based on the best mea-
surement and analytical tools currently available, so yesinfers a clear justi-
cation for standard dietary advice to be modied on the basis of this
variable in most cases.
Fixed/stable characteristics could inform lifelong personalised nutrition
based on a single static measurement, so noinfers that personalisation
must be constantly adapted based on serial monitoring of the variable in
most cases.
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359
Personalised nutrition 355
genotype and a health outcome are often interpreted
as causal and unidirectional. As elegantly described by
Noble (2008), the dogmatic reductionist view that the
direction of causality flows from genesproteinscells
tissuesorganism inadequately explains biological
processes, as reverse causality is a possibility in this
context. This is clearly the case for the gut micro-
biome, whereby the nutritiongut microbiome causal
link flows in both directions (David et al. 2014). Gene
expression is also regulated by ‘higher’ processes, such
as by DNA methylation and histone modification
(Fraga et al. 2005; Qiu 2006). Strong associations
between a genotype and risk of obesity have been
demonstrated. For example, a common variant in the
FTO gene is associated with a 67% increased risk of
obesity, compared to not inheriting the risk allele
(Frayling et al. 2007). However, this strong associa-
tion is not consistent across different conditions. In
physically active individuals, this association between
FTO genotype and body mass is either attenuated or
abolished (Vimaleswaran et al. 2009). This beha-
vioural uncoupling of genotype with an outcome is
not uncommon; physical activity reduces the associa-
tion between genotype and obesity risk based on 12
genetic loci by 40% (Li et al. 2010). These examples
demonstrate that behavioural and environmental fac-
tors have a profound effect on energy balance and
confound congenital effects. Moreover, there is insuffi-
cient evidence of variability between people to justify
the use of personalised nutrition guidelines over com-
mon guidelines across people.
Therefore, on the basis that genotypic and gut
microbial variation in isolation may currently have
limited predictive power in relation to the health out-
comes that a nutritional intervention might be person-
alised to prevent/treat, it is perhaps understandable
why neither individual genotyping or gut microbiome
analysis alone can confidently predict the magnitude
of phenotypic response to that intervention. One
approach to personalised nutrition might, therefore,
be not to predict responsiveness to an intervention
using a static cross-sectional snapshot to profile across
a population but rather to measure within each indi-
vidual to see who actually responds positively to the
intervention over time (i.e. an individual’s initial
response upon first exposure to an intervention
becomes the predictor for their future responses).
However, this introduces a further question about
whether an individual’s observed physiological
response to intervention on one occasion can be taken
as evidence that they are a dependable ‘responder’ and
their future nutrition personalised accordingly.
Can measuring individual responses predict
who would benefit from personalised
nutrition?
Longitudinal/repeated measures studies, ideally within
a testretest experimental design, can be a highly effec-
tive way to establish the magnitude of response to an
intervention over time at a group level. Moreover, it
has rightly become more common in recent years for
scientific experiments to be more sensitive to the consis-
tency of responses from baseline to follow-up at an
individual level (i.e. prepost-intervention change
scores). The latter is a key step in understanding the
determinants of intra-individual responses and thus to
personalising nutrition. This may therefore partly
explain the emerging trend for such inter-individual
differences to be interpreted as evidence of distinct
‘responders’ and ‘non-responders’ in a population
(Fig. 1a), presumably to provide the required categories
for personalisation of that particular intervention.
However, in many cases, the apparent individual
differences in response are merely the result of noise/
error in measurement and/or natural testretest oscilla-
tions in human response, as eloquently explained and
comprehensively demonstrated using a simulated data
set (Atkinson & Batterham 2015). This point is simply
illustrated by reformatting Figure 1a to a frequency
histogram which clearly is not inconsistent with the
normal distribution that might be expected for the
error in measuring naturally occurring physiological
responses (Fig. 1b). For example, the mass of most
objects can generally be measured with relative objec-
tivity and accuracy (i.e. not a ‘noisy’ measurement per
se), yet if the object in question is a living organism
(e.g. a person) then factors such as hydration, recent
voiding and food intake could introduce random
errors if not standardised prepost-intervention, such
that for every ‘Mike’ there is a ‘Phil’ due to natural
over-/under-estimates of measurement (plus/minus ran-
dom variation) at both follow-up and baseline (the lat-
ter also introducing the possibility of statistical
regression and interactive/sensitising effects of pre-test-
ing). Therefore, based solely on one solitary group
receiving an intervention (even using a perfect mea-
surement tool), the most that might be legitimately
concluded is that Mike can be labelled as ‘responded
(i.e. lost weight on this occasion), with no inference
whatsoever as to whether he may be a dependable
‘responder likely to exhibit similar effects of the same
intervention in future.
There is increasing awareness amongst researchers
that reporting only measures of central tendency and
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359
356 J. A. Betts and J. T. Gonzalez
variability (e.g. mean and standard deviation) can be
uninformative and ‘miss’ important patterns in data
(Weissgerber et al. 2015). Thankfully, modern pub-
lishing and archiving practices now enable raw data to
be made available as supplementary or linked files, so
interested readers have the opportunity to fully
explore inter-individual responses. However, these
advances in awareness and data sharing must be cou-
pled with recognition that certain methods of express-
ing and/or interpreting individual data can be
misleading for people who are receptive to messages
highlighting that they may be one of a minority of
possible ‘responders’. Most consumers ultimately just
want to know will this product or intervention work
for me?, and some may be uncertain or even sceptical
about whether a group average applies to them. Of
course, by definition, the appropriate summary statis-
tics do provide a relatively accurate descriptor for the
majority of people (e.g. 6895% within 12 standard
deviations of the mean). Therefore, before any individ-
ual can be identified as an outlier for whom standard
dietary guidelines may not be appropriate, we must:
(i) be confident that a more personalised approach is
justified by the proper analyses applied to the correct
variables; and (ii) empirically demonstrate that this
approach provides a benefit over standard approaches.
Implications and possible solutions
As discussed earlier, current methods of profiling
across a population to fit groups of people into dis-
crete categories are largely ineffective for identifying
inter-individual differences that genuinely warrant
personalised nutrition. Part of the problem with this
approach might well be that ‘the role of genotypic
variation in common non-communicable diseases is
essentially overwhelmed by environmental, cultural
and behavioural factors’ (Joyner & Prendergast 2014).
Indeed, a key confounding factor when assessing the
role of congenital differences between groups of peo-
ple appears to be lifestyle variance within each indi-
vidual. Therefore, rather than trying to control or
adjust for this confounding influence, it may be more
prudent to take full advantage of recent advances in
monitoring such lifestyle factors and use them (within
the constraints of measurement error and biological
variability) as the primary determinants informing
personalisation.
Table 1 lists a number of organismic variables that
have been used to try and personalise nutrition (first
column). The second column summarises how neither
profiling the genome or microbiome nor even sex dif-
ferences justify a clear and consistent deviation from
standard dietary guidelines for any particular category
within those variables (e.g. in general, men and
women can avoid ill health equally well without the
need to personalise nutrition according to sex differ-
ences). Thereafter, a number of additional variables
are listed which could inform personalised nutrition in
order to meet a substantially altered requirement and/
or favour more positive health outcomes. Some of
those listed are self-evident, such as changes in nutri-
ent synthesis/requirements over the lifespan (i.e. age);
greater absolute requirements for most nutrients to
sustain a larger overall body mass vs. advisable reduc-
tions in energy intake in cases of excessive adiposity
(i.e. body/fat mass); the well-established need for
increased intake of certain nutrients prior to, during
Figure 1 Hypothetical sketch illustrating how the common presentation of respondersvs. non-responders(a) can be reformatted to a frequency histogram
showing normally distributed measurement error (b).
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359
Personalised nutrition 357
and after pregnancy; and clear dietary restrictions with
certain allergies, intolerances or disease states. Physical
activity on the other hand remains poorly understood
yet represents the most variable component of energy
expenditure (both between and within individuals)
and therefore the single factor with greatest potential
to adjust both energy requirements and metabolic sub-
strate availability (e.g. via muscle and liver glycogen
depletion). However, beyond widespread recognition
that a physically active individual may need to con-
sume more food in general and often in the form of
carbohydrate (Williams 1989), there appears to be
limited information available about other specific con-
siderations. For example, are any links between diet-
ary sugars and poor health outcomes offset if the
ingested sugar is immediately metabolised during exer-
cise; how much are vitamin B requirements elevated
by various types and patterns of physical activity; and
do exercise-induced sweat sodium losses justify
exceeding recommended limits of salt intake?
Of all these factors with the potential to predict the
benefits of personalised nutrition, the third column
then indicates which one can generally be considered a
fixed or stable characteristic of an individual. The
implication is therefore that only sex, allergy/intoler-
ance and disease state can generally be assessed/diag-
nosed on the basis of a single, static measurement that
can then inform future treatment thereafter. In con-
trast, other interrelated factors such as age, body/fat
mass and even pregnancy all vary naturally through-
out life and might therefore require transient and con-
stantly adapted personalisation of nutrition. Again,
physical activity is a unique case here as this variable
fluctuates much more acutely on a day-to-day basis
and so epitomises the suggestion that rather than per-
sonalising what certain types people should eat every
day we might do better to personalise what every per-
son should eat on certain types of day. Not only
would this dynamic approach be more consistent with
the observation that the fixed differences between us
are generally smaller than the modifiable daily vari-
ance within each person but would also be conducive
to general recommendations for a more varied diet.
In this way, a diet personalised according to activity
levels could be based on a wider framework of overall
energy balance and recognise that the most effective
health-gain strategies involve simultaneous modifica-
tion of both diet and lifestyle, partly due to interactions
whereby adequate physical activity supports appropri-
ate appetite regulation (Blundell & King 1999; Hill
et al. 2012). An optimal diet can therefore be person-
alised not only to what an individual is currently doing
but to what they should be doing. To return to our ear-
lier example, recent trials exploring the relative merits
of modified dietary intake of carbohydrates or sugars
in relation to obesity are almost exclusively conducted
in the context of the general population who typically
fall far short of health guidelines for taking physical
activity or exercise. The conclusions drawn may then
be specific to individuals who are sedentary (which can
be worse for health than obesity per se), in which case
the recommendations made may be inappropriate for
individuals leading an otherwise healthy and active life-
style (potentially even causing lower energy expendi-
ture if inadequate carbohydrate availability reduces the
motivation or ability to partake in physical exertion).
Conversely, tailoring nutrition not to the person (i.e.
personalised nutrition) but dynamically as most appro-
priate to the varying demands and requirements we
face on a daily, weekly, seasonal and lifespan basis
might represent a more effective method of what might
be better referred to as precision nutrition.
Conclusions
Whilst the idea of personalised nutrition might appeal
to our intuition, in this article we have applied logical
reasoning to several examples where the underlying
science calls for a second look at that way of thinking
(i.e. an ‘intuition pump’; Dennett 2014). This is not to
say that we are all the same and that inter-individual
differences between us do not exist; certainly some are
even of sufficient magnitude that they can be measured
and cannot be either tolerated or rectified by our physi-
ology, so may genuinely justify a personalised (or at
least stratified) approach to nutrition. Nonetheless, the
key point put forward in this opinion piece is that these
cases are a rare minority, such that the inter-individual
differences that separate most people are smaller and
less important than the day-to-day variance within each
of us. Accordingly, precision nutrition is a more attrac-
tive prospect than personalised nutrition. In other
words, what makes you special with regard to nutrition
is not who you are but what you do.
Conflict of interest
The authors have no conflict of interest to disclose.
References
Atkinson G & Batterham AM (2015) True and false interindividual
differences in the physiological response to an intervention. Exper-
imental Physiology 100: 577588.
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359
358 J. A. Betts and J. T. Gonzalez
Blundell JE & King NA (1999) Physical activity and regulation of
food intake: current evidence. Medicine and Science in Sports and
Exercise 31: S573S583.
Byrne CS, Chambers ES, Morrison DJ et al. (2015) The role of short
chain fatty acids in appetite regulation and energy homeostasis.
International Journal of Obesity 39: 13311338.
Celis-Morales C, Livingstone KM, Marsaux CFM et al. (2016)
Effect of personalized nutrition on health-related behaviour
change: evidence from the Food4me European randomized con-
trolled trial. International Journal of Epidemiology. doi:10.1093/
ije/dyw186.
David LA, Maurice CF, Carmody RN et al. (2014) Diet rapidly and
reproducibly alters the human gut microbiome. Nature 505: 559
563.
Dennett DC (2014) Intuition Pumps and Other Tools for Thinking.
WW Norton & Co: New York.
Fraga MF, Ballestar E, Paz MF et al. (2005) Epigenetic differences
arise during the lifetime of monozygotic twins. Proceedings of the
National Academy of Sciences of the United States of America
102: 1060410609.
Frayling TM, Timpson NJ, Weedon MN et al. (2007) A common
variant in the FTO gene is associated with body mass index and
predisposes to childhood and adult obesity. Science 316: 889894.
Fuchsberger C, Flannick J, Teslovich TM et al. (2016) The genetic
architecture of type 2 diabetes. Nature 536:4147.
Gudbjartsson DF, Walters GB, Thorleifsson G et al. (2008) Many
sequence variants affecting diversity of adult human height. Nat-
ure Genetics 40: 609615.
Hill JO, Wyatt HR & Peters JC (2012) Energy balance and obesity.
Circulation 126: 126132.
Jeukendrup A (2014) A step towards personalized sports nutrition:
carbohydrate intake during exercise. Sports Medicine (Auckland,
N. Z.) 44(Suppl 1): S25S33.
Joyner MJ & Prendergast FG (2014) Chasing Mendel: five questions
for personalized medicine. Journal of Physiology 592: 23812388.
Larsen LH, Angquist L, Vimaleswaran KS et al. (2012) Analyses of
single nucleotide polymorphisms in selected nutrient-sensitive
genes in weight-regain prevention: the DIOGENES study. Ameri-
can Journal of Clinical Nutrition 95: 12541260.
Li S, Zhao JH, Luan J et al. (2010) Physical activity attenuates the
genetic predisposition to obesity in 20,000 men and women from
EPIC-Norfolk prospective population study. PLoS Medicine.
doi:10.1371/journal.pmed.10003322
McNulty H (1997) Folate requirements for health in women. Pro-
ceedings of the Nutrition Society 56: 291303.
Morris AP, Voight BF, Teslovich TM et al. (2012) Large-scale asso-
ciation analysis provides insights into the genetic architecture and
pathophysiology of type 2 diabetes. Nature Genetics 44: 981990.
Neish AS (2009) Microbes in gastrointestinal health and disease.
Gastroenterology 136:6580.
Noble D (2008) Claude Bernard, the first systems biologist, and the
future of physiology. Experimental Physiology 93:1626.
Qiu J (2006) Epigenetics: unfinished symphony. Nature 441:143145.
Smith R (2012) Stratified, personalised, or precision medicine. Avail-
able at: http://blogs.bmj.com/bmj/2012/10/15/richard-smith-strati-
fied-personalised-or-precision-medicine/ (accessed 14 September
2016).
Steven S, Hollingsworth KG, Al-Mrabeh A et al. (2016) Very low-
calorie diet and 6 months of weight stability in type 2 diabetes:
pathophysiological changes in responders and nonresponders.
Diabetes Care 39: 808815.
Stocks T, Angquist L, Banasik K et al. (2012) TFAP2B influences
the effect of dietary fat on weight loss under energy restriction.
PLoS ONE 7: e43212.
Vimaleswaran KS, Li S, Zhao JH et al. (2009) Physical activity
attenuates the body mass index-increasing influence of genetic
variation in the FTO gene. American Journal of Clinical Nutrition
90: 425428.
Weissgerber TL, Milic NM, Winham SJ et al. (2015) Beyond bar
and line graphs: time for a new data presentation paradigm. PLoS
Biology 13: e1002128.
Williams C (1989) Diet and endurance fitness. American Journal of
Clinical Nutrition 49: 10771083.
Wolever TM (2016) Personalized nutrition by prediction of gly-
caemic responses: fact or fantasy? European Journal of Clinical
Nutrition 70: 411413.
Zeevi D, Korem T, Zmora N et al. (2015) Personalized nutrition by
prediction of glycemic responses. Cell 163: 10791094.
© 2016 British Nutrition Foundation Nutrition Bulletin,41, 353359
Personalised nutrition 359
... The second definition is similar to the precision nutrition definition. Still, it refers to a research design that incorporates a diverse range of variables that allow for a more precise and complex nutritional approach (Betts & Gonzalez, 2016). Because of this, while a customized diet that bases your diet on your genetic information has already been shown to be successful in numerous studies, including the ones above, it is still possible that precision nutrition lacks adequate proof of success due to its complexity. ...
Article
Nutrigenomics is a study of how the genes and diet of a person interact. An individual's diet regime can drive gene regulation and its downstream ultimatum towards health illness through the food-receptor-gene network. Integrative science of genome-wide association along with nutrigenomics is investigating how genomic variation and receptor-mediated nutrient-sensing can optimize and maintain cellular homeostasis. Current scientific understandings have urged nutritional research to shift from traditional epidemiology and physiology to molecular biology, genetics and nutrigenomics which focus on deciphering the genomic, transcriptomic, proteomic and metabolomic effects of both nutrient deficiency and toxicity. From nutrigenomics point of view, nutrients are the potent signals/sensors that direct specific cells to undergo metabolic changes determining the result as a healthy or diseased individual. The varying cell sensing pattern towards a particular diet is known as ‘dietary signature’ that can be exploited for tailoring functional food and precision nutrition. ‘Data mining’ and various bioinformatics tools are helpful towards evidence-based intervention strategies by decoding nutrigenomics data as an ultimatum of which sound health is restored and diseases are prevented. This review is an attempt for the conglomeration of evolution of nutrigenomics, genome interaction and exploration of genomic tools to develop precision nutrition and food-based related disease.
... As a result, the size of the international plant-based protein market is predicted to increase from US$10.3 billion in 2020 to US$14.5 billion by 2025 (Askew, 2021). Food trends are moving from healthy innovation to personalized nutrition (Archer et al., 2017;Betts & Gonzalez, 2016) with functional foods an emerging area. Moreover, it is predicated that the next generation of 3D printing technologies will emerge as the next food trend (Chadwick, 2017), with the ability to create esthetically pleasing and intricately shaped foods, that are more complex in nature, nutritionally balanced, and optimized for texture and taste (Watkins et al., 2022). ...
Article
Full-text available
Ensuring the chemical, physical, and microbial safety of food and ingredients underpins the international trade of food items and is integral to building consumer confidence. Achieving this requires effective systems to support the safety of food across the supply chain. Differing risk‐assessment approaches are utilized globally for establishing food safety systems, and bench marking these approaches against international food safety standards can assist in the development of country‐specific systems. This China–Australia collaborative review examined similarities and differences in the food safety risk‐assessment systems of China, Australia/New Zealand, Canada, and the United States, with the view to identify areas that could support improvements to the Chinese system. Key differences include the level of cohesiveness among stakeholders and the level to which each country promotes the international harmonization of standards. The evidence highlights a need for greater capacity‐building in risk assessment in China that may support greater stakeholders’ cohesion, improve hazard identification, and allow regulators to more readily keep abreast of changes to international standards. This review may help the Chinese food industry to replicate the same level of food safety risk assessment currently applied by other key countries, and reflects the determination, government prioritization, and active strengthening of China's National Centre for Food Safety Risk Assessment currently underway.
... Specifically, genetic and epigenetic factors determine inter-individual variations in the response to diet/nutrition. The latter include inter-individuals' differences in metabolic functions, including those regulating the absorption, bioavailability, metabolism of nutrients and the metabolic function of organs/cells [8][9][10][11][12][13][14]. Recent data suggest that skeletal muscle mass and specifically muscle fibers exhibit an important role, through their fiber-type depending metabolic functions [15][16][17][18][19][20][21] or their contraction-mediated secretion of myokines [22][23][24][25][26]. ...
Article
Full-text available
Systematic, regular high-volume endurance training induces significant metabolic adaptations in glucose and lipids metabolism, which seems to affect the negative impact of unhealthy nutrition, at least in animal models. The present study aimed to investigate the main determinants of body composition, blood glucose and lipids concentrations between middle-aged sedentary individuals (Sed) and well-trained endurance athletes (Run), both following an unhealthy high-fat diet. In thirty-five Sed (Age: 54.0 ± 6.6 yrs, Body Mass: 77.1 ± 10.5 kg, BMI: 31.3 ± 6.0 kg·m−2) and thirty-six Run (Age: 51.6 ± 5.2 yrs, Body Mass: 85.8 ± 3.4 kg, BMI: 23.2 ± 1.8 kg·m−2), body composition, nutritional intake, energy expenditure, resting metabolic rate (RMR), respiratory exchange ratio (RER), and blood glucose and lipids concentrations were evaluated. Multiple linear regression analyses revealed that body composition, blood glucose and lipids’ concentrations in the Run group were primarily determined by the energy expenditure (B: −0.879 to −1.254), while in the Sed group, by their energy intake (B:−0.754 to 0.724). In conclusion, it seems that in well-trained endurance middle-aged athletes, body composition, blood glucose, and lipids concentrations seem to be determined by their training-induced daily energy expenditure and not by their nutritional intake per se. At the same time, nutrition is the primary determinant in aged-matched sedentary individuals, even if they both follow high-fat diets.
... The search for wholesome food patterns that can ameliorate metabolic syndromes resulting from malnutrition and over-nutrition is gaining ground [1,2]. Studies on healthpromoting food components show broad interest in exploring novel dietary patterns. ...
Article
Full-text available
Sirtfood is a new concept food that compounds diets that can target sirtuins (SIRTs). SIRTs are nicotinamide adenine dinucleotide (NAD+)-dependent deacylases and ADP-ribosyltransferases (enzymes). SIRTs are mediators of calorie restriction (CR) and their activation can achieve some effects similar to CR. SIRTs play essential roles in ameliorating obesity and age-related metabolic diseases. Food ingredients such as resveratrol, piceatannol, anthocyanidin, and quinine are potential modulators of SIRTs. SIRT modulators are involved in autophagy, apoptosis, aging, inflammation, and energy homeostasis. Sirtfood proponents believe that natural Sirtfood recipes exert significant health effects.
... In addition, physiological responses to dietary interventions such as satiety and glycemic response vary according to individuals [10]. Different reactions are given to the nutrients taken into the body due to biological processes caused by differences in metabolism, genetic and intestinal microbiota, food consumption, and interindividual differences due to exposure to environmental factors [11]. Considering these differences, personalized diet aiming to improve, maintain and protect against diseases are nutritional recommendations developed individually as a result of the evaluation of the interactions between internal factors such as genetic, microbiome, metabolome interactions of the processes of nutrients in the body, and external factors such as nutritional habits and physical activity [12]. ...
Article
Recent studies have shown that the microbiota, which is rich in variety and amount of nutrients, lives in the intestines and is thought to act as an organ, plays a significant role in the pathogenesis of health and diseases, and its composition is personal. Tailoring the diet, one of the most effective factors in the modulation of microbiota, for the promotion of health, the treatment of obesity, diabetes mellitus, cardiovascular and gastrointestinal system diseases are accepted as a potential therapeutic approach. In addition to practical methods such as anthropometric measurements used in the routine evaluation of nutrition, evaluation of food consumption records, and physical activity, some technological methods have been developed recently after the technology 4.0 revolution, which analyzes the host-microbiome with various methods. Although these next-generation technologies are promising for the evaluation of data on the individual microbiome and dietary interactions and the development of recommendations in this direction, there are several problems in data processing and analysis. Considering the impact of diet-microbiota interaction on health and disease, microbiota-based personalized dietary recommendations are promising, but still, there seems to be some way to go. In this mini-review, the diet-microbiota relationship in a personalized diet approach was evaluated and the potential use or usability of diet planning based on this approach was discussed.
Article
The objective. To evaluate the effectiveness of the 5P-model for the prevention of acute cerebral ischemia in Dagestan women. Materials and methods. The prospective study included 35 women permanently residing in Dagestan. The mean age was 66.46 ± 10.9 years. Each participant of the study was individually interviewed and examined clinically, neurologically, an additional examination included: complete blood test, biochemical blood test, coagulation test, molecular genetic study for 11 candidate gene mutations significant for the occurrence of ischemic stroke, electrocardiography, neuroimaging. Results. By analyzing the results of the study, individual background conditions that predispose to the occurrence of ischemic stroke were established. The results of the examination were explained to each participant, there were given the recommendations on lifestyle modification, a diet was prescribed and the necessary therapy was selected. In the process of dynamic observation for 4 years the observed group had no episodes of acute cerebrovascular accident. Conclusions. The study confirms the effectiveness of the use of the 5P-model for the prevention of acute cerebral ischemia in women Dagestan and declare a positive experience of its application.
Article
Introduction: This cross-sectional study explored whether nutrition, body composition, and physical activity energy expenditure (PAΕΝ) have a differential impact on lipidemic blood profiles among young females with different blood cholesterol concentrations. Methods: One hundred thirty-five young female students (N = 135) were allocated into three groups according to their blood cholesterol concentrations (Chol): (A) Normal [NL; Chol: < 200 mg·dL-1; n = 56 Age: 21.4 ± 2.6 yrs, Body Mass Index (BMI): 22.1 ± 2.0 kg·m-2], (B) Borderline (BL; Chol: ≥200 mg·dL-1 and <240 mg·dL-1; n = 44 Age: 21.6 ± 2.5 yrs, BMI: 24.2 ± 3.1 kg·m-2) and (C) High level (HL; Chol: ≥240 mg·dL-1; n = 35 Age: 22.5 ± 2.4 yrs, BMI: 28.9 ± 2.1 kg·m-2). Body composition [bioelectrical impedance analysis including lean body mass (LBM) and body fat mass], nutritional intake (recall questionnaire), daily physical activity energy expenditure through activity trackers and resting blood lipids concentrations were evaluated. Results: Multiple linear regression analyses revealed that in the NL group, lean mass, daily PAΕΝ and daily energy balance were the determinant parameters of blood lipidemic profiles (B: -0.815 to 0.700). In the BL group, nutrition, body composition and daily physical activity energy expenditure exhibited similar impacts (B: -0.440 to 0.478). In the HL group, nutritional intake and body fat mass determined blood lipidemic profile (B: -0.740 to 0.725). Conclusion: Nutrition, body composition and daily PAΕΝ impact on blood lipids concentration is not universal among young females. In NL females, PAEN, energy expenditure and LBM are the strongest determinants of blood lipids, while in HL females, nutritional intake and body fat mass are. As PAΕΝ increases, the importance of nutrition and body fat decreases, and vice versa.
Chapter
Precision food emphasizes on providing a nutritious diet tailored to the individual's health needs and improves functional status and quality of life by increasing energy levels. Several factors, including biology, eating patterns, food behavior, physical activity, metabolome, and gut microbiota, are worth considering while designing precision food. Nutrients play the major role by controlling metabolic processes and influence the expression of enzymes, receptors, hormones, and other proteins. Nutrigenomics-based personalized diet focuses on various health conditions including metabolic syndromes. Agri genomics, employing biofortification, provides a more integrated and streamlined preparation of biotechnology crop that could lead to improved nutritional properties. In fermentation bioprocessing, genetically modified microbial cultures are used to improve food attributes. Personalized nutrition also has the potential to alter host–microbiota interactions. Advances in technology, such as the multiomics approach, which includes nutrigenomics, metabolomics, and proteomics, as well as artificial intelligence, have enabled rapid measurements and progress toward precision nutrition by assisting people in changing their eating habits and choosing a healthy lifestyle.
Article
Impaired metabolism is the cause of several health issues, such as obesity, diabetes, dyslipemia, polycistic ovary syndrome, hypertension and other cardiovascular complications, creating a growing concern worldwide and leading to diminished life expectancy. New strategies are needed to increase the efficacy of prevention and management of these diseases. Personalized nutrition aims to prevent and manage chronic diseases by tailoring dietary recommendations taking into account the interaction between an individual’s biology, lifestyle, behavior, and environment. The progress in genomics, metabolomics, and gut microbiome technologies has opened opportunities in the use of precision nutrition to prevent and manage metabolic diseases. This review describes the perspectives of nutrigenetics, deep phenotyping, microbiota profiling, family and personal clinical cues, and a wide spectrum of data concerning metabolic personalization through omics technologies (metabolomics, epigenomics, metagenomics, and others) in tailoring dietary and lifestyle advices as a part of the prevention and management programs targeting metabolic diseases. The review also discusses advances and challenges in analyzing and monitoring eating habits, eating behavior, physical activity, and deep phenotyping, as well as the examples of successful applications of computer programs to implement mobile applications with personalized nutrition techniques in clinical practice.
Article
Full-text available
The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified scores of common variants associated with type 2 diabetes, but in aggregate, these explain only a fraction of the heritability of this disease. Here, to test the hypothesis that lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES consortia performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing in 12,940 individuals from five ancestry groups. To increase statistical power, we expanded the sample size via genotyping and imputation in a further 111,548 subjects. Variants associated with type 2 diabetes after sequencing were overwhelmingly common and most fell within regions previously identified by genome-wide association studies. Comprehensive enumeration of sequence variation is necessary to identify functional alleles that provide important clues to disease pathophysiology, but large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes.
Article
Full-text available
Objective: Type 2 diabetes mellitus (T2DM) is generally regarded as an irreversible chronic condition. Because a very-low-calorie diet (VLCD) can bring about acute return to normal glucose control in some people with T2DM, this study tested the potential durability of this normalization. The underlying mechanisms were defined. Research design and methods: People with a T2DM duration of 0.5-23 years (n = 30) followed a VLCD for 8 weeks. All oral agents or insulins were stopped at baseline. Following a stepped return to isocaloric diet, a structured, individualized program of weight maintenance was provided. Glucose control, insulin sensitivity, insulin secretion, and hepatic and pancreas fat content were quantified at baseline, after return to isocaloric diet, and after 6 months to permit the primary comparison of change between post-weight loss and 6 months in responders. Responders were defined as achieving fasting blood glucose <7 mmol/L after return to isocaloric diet. Results: Weight fell (98.0 ± 2.6 to 83.8 ± 2.4 kg) and remained stable over 6 months (84.7 ± 2.5 kg). Twelve of 30 participants achieved fasting plasma glucose <7 mmol/L after return to isocaloric diet (responders), and 13 of 30 after 6 months. Responders had a shorter duration of diabetes and a higher initial fasting plasma insulin level. HbA1c fell from 7.1 ± 0.3 to 5.8 ± 0.2% (55 ± 4 to 40 ± 2 mmol/mol) in responders (P < 0.001) and from 8.4 ± 0.3 to 8.0 ± 0.5% (68 ± 3 to 64 ± 5 mmol/mol) in nonresponders, remaining constant at 6 months (5.9 ± 0.2 and 7.8 ± 0.3% [41 ± 2 and 62 ± 3 mmol/mol], respectively). The responders were characterized by return of first-phase insulin response. Conclusions: A robust and sustainable weight loss program achieved continuing remission of diabetes for at least 6 months in the 40% who responded to a VLCD by achieving fasting plasma glucose of <7 mmol/L. T2DM is a potentially reversible condition.
Article
Full-text available
Over the last 20 years there has been an increasing interest in the influence of the gastrointestinal tract on appetite regulation. Much of the focus has been on the neuronal and hormonal relationship between the gastrointestinal tract and the brain. There is now mounting evidence that the colonic microbiota and their metabolic activity play a significant role in energy homeostasis. The supply of substrate to the colonic microbiota has a major impact on the microbial population and the metabolites they produce, particularly short chain fatty acids (SCFAs). SCFAs are produced when non-digestible carbohydrates, namely dietary fibres and resistant starch, undergo fermentation by the colonic microbiota. Both the consumption of fermentable carbohydrates and the administration of SCFAs have been reported to result in a wide range of health benefits including improvements in body composition, glucose homeostasis, blood lipid profiles, and reduced body weight and colon cancer risk. However, published studies tend to report the effects that fermentable carbohydrates and SCFAs have on specific tissues and metabolic processes, and fail to explain how these local effects translate into systemic effects and the mitigation of disease risk. Moreover, studies have tended to investigate SCFAs collectively and neglect to report the effects associated with individual SCFAs. Here, we bring together the recent evidence and suggest an overarching model for the effects of SCFAs on one of their beneficial aspects: appetite regulation and energy homeostasis.International Journal of Obesity accepted article preview online, 14 May 2015. doi:10.1038/ijo.2015.84.
Article
Background Optimal nutritional choices are linked with better health, but many current interventions to improve diet have limited effect. We tested the hypothesis that providing personalized nutrition (PN) advice based on information on individual diet and lifestyle, phenotype and/or genotype would promote larger, more appropriate, and sustained changes in dietary behaviour. Methods : Adults from seven European countries were recruited to an internet-delivered intervention (Food4Me) and randomized to: (i) conventional dietary advice (control) or to PN advice based on: (ii) individual baseline diet; (iii) individual baseline diet plus phenotype (anthropometry and blood biomarkers); or (iv) individual baseline diet plus phenotype plus genotype (five diet-responsive genetic variants). Outcomes were dietary intake, anthropometry and blood biomarkers measured at baseline and after 3 and 6 months’ intervention. Results At baseline, mean age of participants was 39.8 years (range 18–79), 59% of participants were female and mean body mass index (BMI) was 25.5 kg/m2. From the enrolled participants, 1269 completed the study. Following a 6-month intervention, participants randomized to PN consumed less red meat [-5.48 g, (95% confidence interval:-10.8,-0.09), P = 0.046], salt [-0.65 g, (−1.1,-0.25), P = 0.002] and saturated fat [-1.14 % of energy, (−1.6,-0.67), P < 0.0001], increased folate [29.6 µg, (0.21,59.0), P = 0.048] intake and had higher Healthy Eating Index scores [1.27, (0.30, 2.25), P = 0.010) than those randomized to the control arm. There was no evidence that including phenotypic and phenotypic plus genotypic information enhanced the effectiveness of the PN advice. Conclusions Among European adults, PN advice via internet-delivered intervention produced larger and more appropriate changes in dietary behaviour than a conventional approach.
Article
The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified scores of common variants associated with type 2 diabetes, but in aggregate, these explain only a fraction of the heritability of this disease. Here, to test the hypothesis that lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES consortia performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing in 12,940 individuals from five ancestry groups. To increase statistical power, we expanded the sample size via genotyping and imputation in a further 111,548 subjects. Variants associated with type 2 diabetes after sequencing were overwhelmingly common and most fell within regions previously identified by genome-wide association studies. Comprehensive enumeration of sequence variation is necessary to identify functional alleles that provide important clues to disease pathophysiology, but large-scale sequencing does not support the idea that lower-frequency variants have a major role in predisposition to type 2 diabetes.
Article
European Journal of Clinical Nutrition is a high quality, peer-reviewed journal that covers all aspects of human nutrition.
Article
Elevated postprandial blood glucose levels constitute a global epidemic and a major risk factor for prediabetes and type II diabetes, but existing dietary methods for controlling them have limited efficacy. Here, we continuously monitored week-long glucose levels in an 800-person cohort, measured responses to 46,898 meals, and found high variability in the response to identical meals, suggesting that universal dietary recommendations may have limited utility. We devised a machine-learning algorithm that integrates blood parameters, dietary habits, anthropometrics, physical activity, and gut microbiota measured in this cohort and showed that it accurately predicts personalized postprandial glycemic response to real-life meals. We validated these predictions in an independent 100-person cohort. Finally, a blinded randomized controlled dietary intervention based on this algorithm resulted in significantly lower postprandial responses and consistent alterations to gut microbiota configuration. Together, our results suggest that personalized diets may successfully modify elevated postprandial blood glucose and its metabolic consequences. VIDEO ABSTRACT.